BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10967792)

  • 1. Issues in the treatment of metastatic breast cancer.
    Barse PM
    Semin Oncol Nurs; 2000 Aug; 16(3):197-205. PubMed ID: 10967792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting metastatic and advanced breast cancer.
    Moore S; Cobleigh MA
    Semin Oncol Nurs; 2007 Feb; 23(1):37-45. PubMed ID: 17303515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast cancer: understanding current management options.
    McGinn K; Moore J
    Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Educational and psychosocial issues related to new treatment advances for metastatic breast cancer.
    Knoop T
    Semin Oncol Nurs; 2000 Nov; 16(4 Suppl 1):18-22. PubMed ID: 11151454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer.
    Ouwerkerk J; Boers-Doets C
    Eur J Oncol Nurs; 2010 Sep; 14(4):337-49. PubMed ID: 20580896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic management of advanced ovarian cancer.
    Gordon AN; Butler J
    Semin Oncol Nurs; 2003 Aug; 19(3 Suppl 1):3-18. PubMed ID: 12971247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New diagnostic techniques and treatments for early breast cancer.
    Mautner BD; Schmidt KV; Brennan MB
    Semin Oncol Nurs; 2000 Aug; 16(3):185-96. PubMed ID: 10967791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine in oncology standard of care.
    Adams L
    Semin Oncol Nurs; 2014 May; 30(2):100-8. PubMed ID: 24794083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced breast cancer: recent developments in hormonal therapy.
    Cloutier AO
    Semin Oncol Nurs; 2000 Aug; 16(3):206-13. PubMed ID: 10967793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine therapy in breast cancer: the neoadjuvant, adjuvant, and metastatic approach.
    Reinbolt RE; Mangini N; Hill JL; Levine LB; Dempsey JL; Singaravelu J; Koehler KA; Talley A; Lustberg MB
    Semin Oncol Nurs; 2015 May; 31(2):146-55. PubMed ID: 25951743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment options for metastatic breast cancer: what now?
    Rugo HS; O'Shaughnessy JA; Perez EA
    Clin Adv Hematol Oncol; 2011 Nov; 9(11 Suppl 25):1-16. PubMed ID: 22362269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for improving quality of life in older patients with metastatic breast cancer.
    Kurtz JE; Dufour P
    Drugs Aging; 2002; 19(8):605-22. PubMed ID: 12207554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment for breast cancer: chemotherapy and biotherapy agents.
    Bourdeanu L; Liu EA
    Semin Oncol Nurs; 2015 May; 31(2):156-62. PubMed ID: 25951744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic approaches in young women with advanced or metastatic breast cancer.
    GarcĂ­a Palomo A
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():49-52. PubMed ID: 20711655
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of chemotherapy in metastatic breast cancer.
    Garber JE; Henderson IC
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):807-21. PubMed ID: 2481671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The breast cancer panel: a case-based discussion on the use of targeted therapies for primary and metastatic disease.
    Fortenbaugh C
    ONS News; 2006; 21(8 Suppl):37-8. PubMed ID: 16925144
    [No Abstract]   [Full Text] [Related]  

  • 17. New developments in metastatic breast cancer: general discussion.
    Vahdat LT; Rugo HS; Perez EA
    Clin Adv Hematol Oncol; 2013; 11(10 Suppl 16):16-7. PubMed ID: 24765684
    [No Abstract]   [Full Text] [Related]  

  • 18. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eribulin rapidly reduces the aggressiveness of second primary breast cancer: a case report.
    Falco I; Stragliotto S
    Future Oncol; 2017 Apr; 13(11s):51-54. PubMed ID: 28481187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transition experience to breast cancer survivorship.
    Knobf MT
    Semin Oncol Nurs; 2015 May; 31(2):178-82. PubMed ID: 25951747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.